TY - BOOK AU - Xiangdong Wang TI - Bioinformatics of Human Proteomics T2 - Translational bioinformatics, v. 3 SN - 9789400758100 U1 - 572.6 BIO PY - 2013/// CY - Dordrecht PB - Springer KW - Bioinformatics. Proteomics. Biological models. N1 - Clinical Bioinformatics in Human Proteomics Research.- Proteomics defines protein interaction.- Protein Function Microarrays: Design, Use and Bioinformatic Analysis in Cancer Biomarker Discovery and Quantitation.- Proteomics and Cancer Research.- Towards development of novel peptide-based cancer therapeutics: computational design and experimental evaluation.- Advances of proteomic methods.- Clinical and Biomedical Mass Spectrometry - New Frontiers in Drug Developments and Diagnosis.- Disease biomarkers: Modeling MR spectroscopy and clinical applications.- Processing of mass spectrometry data in clinical applications.- Bioinformatics approach for finding target protein in infectious disease.- Identification of network biomarkers for cancer diagnosis.- Software development for quantitative proteomics using stable isotope labeling.- Clinical translation of protein biomarkers integrated with bioinformatics.- Proteomic approaches for urine biomarker discovery in bladder cancer.- Antibody microarray and multiplexing.-Proteomics in Anaesthesia and Intensive Care Medicine N2 - Bioinformatics of Human Proteomics? discusses the development ofmethods, techniques and applications in the field of proteinbioinformatics, an important direction in bioinformatics. Itcollects contributions from expert researchers in order to providea practical guide to this complex field of study. The book coversthe protein interaction network, drug discovery and development,the relationship between translational medicine and bioinformatics,and advances in proteomic methods, while also demonstratingimportant bioinformatics tools and methods available today forprotein analysis, interpretation and predication. It is intendedfor experts or senior researchers in the fields of clinicalresearch-related biostatistics, bioinformatics, computationalbiology, medicine, statistics, system biology, moleculardiagnostics, biomarkers, or drug discovery and development.Dr.Xiangdong Wang works as a distinguished professor of RespiratoryMedicine at Fudan University, Shanghai, China. He serves asDirector of Biomedical Research Center, Fudan University ZhongshanHospital and adjunct professor of Clinical Bioinformatics at LundUniversity, Sweden. His main research is focused on the role ofclinical bioinformatics in the development of disease-specificbiomarkers and dynamic network biomarkers, the molecular mechanismof organ dysfunction and potential therapies ER -